Emory Healthcare · 3 weeks ago
Nuclear Med Technologist
Emory Healthcare is one of the nation's leading hospitals in various medical fields, including cardiology and cancer treatment. The Nuclear Med Technologist will provide quality care to patients undergoing diagnostic and interventional radiology procedures, operate imaging equipment, and administer radiopharmaceuticals for diagnostic purposes.
Health CareMedical
Responsibilities
Provides quality care to the patients receiving diagnostic and interventional radiology procedures
Assumes responsibility and provides direct quality care for patients receiving Nuclear Medicine and PET exams
Responsible for proper operation of imaging and specialty equipment as well as keeps abreast of uses of medical devices
Explains procedures to patients to reduce their anxiety and obtain patient cooperation
Assists with patient/family education
Performs efficiently in emergency situations
Prepares, measures and administers radiopharmaceuticals in diagnostic procedures
Responsible for acquiring, processing and photographing optimum exams for diagnostic interpretation
Qualification
Required
Must be a graduate of an accredited school of Nuclear Medicine Technology
Be registered in Nuclear Medicine with the ARRT or the Nuclear Medicine Technology Certification Board (NMTCB)
Must have a minimum of two (2) years experience
Basic Life Support (BLS) Certification in accordance with the American Heart Association required
Company
Emory Healthcare
Emory Healthcare is the largest healthcare system in the state of Georgia., United States.
H1B Sponsorship
Emory Healthcare has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (48)
2024 (68)
2023 (30)
2022 (25)
2021 (12)
2020 (7)
Funding
Current Stage
Late StageRecent News
2025-09-01
Company data provided by crunchbase